Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
about
A cohort study of vitamin D intake and melanoma riskVitamin D metabolism and action in human bone marrow stromal cellsVitamins and MelanomaNew vitamin D analogs as potential therapeutics in melanomaCutaneous vitamin D synthesis versus skin cancer development: The Janus faces of solar UV-radiation.Immunohistochemical evaluation of vitamin D receptor (VDR) expression in cutaneous melanoma tissues and four VDR gene polymorphisms.Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study.Pre-diagnostic plasma 25-hydroxyvitamin D levels and risk of non-melanoma skin cancer in women.Vitamin D and cancer.Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial.Why vitamin D for cancer patients?Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.Pilot study on the bioactivity of vitamin d in the skin after oral supplementationVitamin D Intake and Risk of Skin Cancer in US Women and MenSerum level of vitamin D3 in cutaneous melanomaVitamin D in cutaneous carcinogenesis: part IVitamin D in cutaneous carcinogenesis: part II.Cytochromes p450 and skin cancer: role of local endocrine pathways.Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival.Melanoma and vitamin DVitamin D: metabolism, molecular mechanisms, and mutations to malignancies.Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines.Activation of vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling pathways through 1,25(OH)(2)D(3) in melanoma cell lines and other skin-derived cell linesNo evidence for induction of key components of the Notch signaling pathway (Notch-1, Jagged-1) by treatment with UV-B, 1,25(OH)(2)D(3), and/or epigenetic drugs (TSA, 5-Aza) in human keratinocytes in vitro.The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms.Epidemiology of melanoma: is it still epidemic? What is the role of the sun, sunbeds, Vit D, betablocks, and others?Identification of Genotypes and Allelic Frequencies of Vitamin D Receptor Gene Polymorphism (TaqI) in Egyptian Melasma Patients.Narrow-band UVB effects on cutaneous vitamin D receptor expression and serum 25-hydroxyvitamin D in generalized vitiligo.Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphismAntiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 ReceptorsExtrahepatic 25-Hydroxylation of Vitamin D3 in an Engineered Osteoblast Precursor Cell Line Exploring the Influence on Cellular Proliferation and Matrix Maturation during Bone Development
P2860
Q24646333-90BAC67A-8BB6-43FB-AEA2-BA49F9BB69C7Q24649058-744958CE-0F8C-4526-A505-F2B383F61501Q26799314-8950C7BA-24CB-4160-81CC-E18C99BC55B1Q27001080-3C114BFD-9401-4661-AACD-D5B373961994Q33718913-E6556F85-CC02-4050-B851-696477D9E4EBQ33728928-99A2F200-D62B-4243-8F99-48AC6519374FQ34121847-8162D057-D137-4C9A-8BFE-867F325CD412Q34228600-1868EF71-B270-4640-8F55-56E51A77738BQ34278228-C78D213D-054D-4B43-84CC-8541A96F1271Q34588331-CCD3E57E-A3D6-4EF3-B553-23F091C40077Q35170221-A43931CF-5799-46DD-830C-BF5F406F7A1BQ35572937-A335D2E6-9480-4CF6-A196-A383D5149A3DQ35603114-C7DFC6F8-0BC3-4D9D-8EC6-2A5F2A77A6E2Q35880703-4B48C004-06D6-4A9E-B357-F1BDB4C1F7A5Q36111623-4AFF58BB-D789-4662-A335-52489667B517Q36934873-CA63270E-15BB-4E05-B1DE-FEA2742C6CAFQ36944593-9CE1076F-5117-4B9B-AD5B-9D5E7829285BQ36996576-12F9C547-35C0-4901-A5B6-7CF1EACAA8EBQ37088368-3D849B89-0EBF-46D3-B3AD-E2AE4F37147FQ37611428-DE71835D-DD69-4DAB-9A6D-6F1262921B35Q37849442-B264135B-8C40-4B55-B361-429ABC33E614Q38077504-86516609-21C3-4847-A48A-695887FCB28FQ38804186-DB66C2DD-FFBE-49EA-8EA3-C41C871D8C60Q39533263-F619F636-E854-4C39-94C1-36838B9F69E5Q41849348-E186AFB2-E4ED-4A44-8279-1696C28CEFF2Q42416249-4094566D-1DF3-4021-B00B-804B50F2F709Q44322484-B9049DC7-0D01-4199-BCBD-1336145CACC3Q47284583-FD9D2D73-4F82-41BB-90A5-256201A91A09Q48109339-4F0CFB97-7BCD-4E65-A489-BE6CB0DA82E3Q48218051-51457C6C-5D08-48C8-82F8-662FA5E83DFEQ57665224-B7209BFC-5B67-4954-B6BD-8D5D017DA603Q58779190-49228BC6-93F2-4828-949F-C64D81FDB288Q59001491-01CF9939-6B05-4122-9557-92F61236182D
P2860
Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Differential biological effect ...... melanoma cell lines in vitro.
@en
type
label
Differential biological effect ...... melanoma cell lines in vitro.
@en
prefLabel
Differential biological effect ...... melanoma cell lines in vitro.
@en
P2093
P1476
Differential biological effect ...... melanoma cell lines in vitro.
@en
P2093
Jörg Reichrath
Markus Seifert
Martin Rech
Viktor Meineke
Wolfgang Tilgen
P304
P356
10.1016/J.JSBMB.2004.03.002
P577
2004-05-01T00:00:00Z